---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285555751.md"
description: "Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results."
datetime: "2026-05-07T12:46:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285555751.md)
  - [en](https://longbridge.com/en/news/285555751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285555751.md)
generator: "portal-rs"
---

# 

Entrada Therapeutics shares are trading lower after the company reported mixed Q1 financial results.

### Related Stocks

- [TRDA.US](https://longbridge.com/en/quote/TRDA.US.md)

## Related News & Research

- [Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells 14,569 Shares of Stock](https://longbridge.com/en/news/297116833.md)
- [Bioventures 2014 L.P. Mpm Sells 21,623 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock](https://longbridge.com/en/news/297116837.md)
- [Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common shares](https://longbridge.com/en/news/294740785.md)
- [Entrada Therapeutics publishes corporate presentation on genetic medicines pipeline for neuromuscular and inherited retinal diseases](https://longbridge.com/en/news/294966190.md)
- [Entrada Therapeutics, Inc. 2026: Revenue $898K, EPS ($1.01) — 10-Q Summary](https://longbridge.com/en/news/294957966.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**